AAAAAA

   
Results: 1-25 | 26-50 |
Results: 26-50/50
THE INHIBITION OF RADIATION-INDUCED MUTAGENESIS BY THE COMBINED EFFECTS OF SELENIUM AND THE AMINOTHIOL WR-1065
Authors: DIAMOND AM DALE P MURRAY JL GRDINA DJ
Citation: Am. Diamond et al., THE INHIBITION OF RADIATION-INDUCED MUTAGENESIS BY THE COMBINED EFFECTS OF SELENIUM AND THE AMINOTHIOL WR-1065, Mutation research, 356(2), 1996, pp. 147-154
THE PROVISION OF SERVICES TO CLIENTS WITH LEARNING-DISABILITIES AND HIV AIDS/
Authors: MURRAY JL MACDONALD RAR
Citation: Jl. Murray et Rar. Macdonald, THE PROVISION OF SERVICES TO CLIENTS WITH LEARNING-DISABILITIES AND HIV AIDS/, International journal of psychology, 31(3-4), 1996, pp. 5833-5833
CHARACTERIZATION OF 13 NOVEL BAND-3 GENE DEFECTS IN HEREDITARY SPHEROCYTOSIS WITH BAND-3 DEFICIENCY
Authors: JAROLIM P MURRAY JL RUBIN HL TAYLOR WM PRCHAL JT BALLAS SK SNYDER LM CHROBAK L MELROSE WD BRABEC V PALEK J
Citation: P. Jarolim et al., CHARACTERIZATION OF 13 NOVEL BAND-3 GENE DEFECTS IN HEREDITARY SPHEROCYTOSIS WITH BAND-3 DEFICIENCY, Blood, 88(11), 1996, pp. 4366-4374
INCIDENTAL ASYMPTOMATIC ORBITAL CALCIFICATIONS
Authors: MURRAY JL HAYMAN LA TANG RA SCHIFFMAN JS
Citation: Jl. Murray et al., INCIDENTAL ASYMPTOMATIC ORBITAL CALCIFICATIONS, Journal of neuro-ophthalmology, 15(4), 1995, pp. 203-208
CHANGES IN AN HER-2 PEPTIDE UP-REGULATING HLA-A2 EXPRESSION AFFECT BOTH CONFORMATIONAL EPITOPES AND CTL RECOGNITION - IMPLICATIONS FOR OPTIMIZATION OF ANTIGEN PRESENTATION AND TUMOR-SPECIFIC CTL INDUCTION
Authors: FISK B SAVARY C HUDSON JM OBRIAN CA MURRAY JL WHARTON JT IOANNIDES CG
Citation: B. Fisk et al., CHANGES IN AN HER-2 PEPTIDE UP-REGULATING HLA-A2 EXPRESSION AFFECT BOTH CONFORMATIONAL EPITOPES AND CTL RECOGNITION - IMPLICATIONS FOR OPTIMIZATION OF ANTIGEN PRESENTATION AND TUMOR-SPECIFIC CTL INDUCTION, Journal of immunotherapy with emphasis on tumor immunology, 18(4), 1995, pp. 197-209
STAFF ATTITUDES TOWARDS INDIVIDUALS WITH LEARNING-DISABILITIES AND AIDS - THE ROLE OF ATTITUDES TOWARDS CLIENT SEXUALITY AND THE ISSUE OF MANDATORY TESTING FOR HIV-INFECTION
Authors: MURRAY JL MACDONALD RAR MINNES PM
Citation: Jl. Murray et al., STAFF ATTITUDES TOWARDS INDIVIDUALS WITH LEARNING-DISABILITIES AND AIDS - THE ROLE OF ATTITUDES TOWARDS CLIENT SEXUALITY AND THE ISSUE OF MANDATORY TESTING FOR HIV-INFECTION, Mental handicap research, 8(4), 1995, pp. 321-332
AN ANTIMELANOMA IMMUNOTOXIN CONTAINING RECOMBINANT HUMAN TUMOR-NECROSIS-FACTOR - TISSUE DISPOSITION, PHARMACOKINETIC, AND THERAPEUTIC STUDIES IN XENOGRAFT MODELS
Authors: ROSENBLUM MG CHEUNG L MUJOO K MURRAY JL
Citation: Mg. Rosenblum et al., AN ANTIMELANOMA IMMUNOTOXIN CONTAINING RECOMBINANT HUMAN TUMOR-NECROSIS-FACTOR - TISSUE DISPOSITION, PHARMACOKINETIC, AND THERAPEUTIC STUDIES IN XENOGRAFT MODELS, Cancer immunology and immunotherapy, 40(5), 1995, pp. 322-328
PHARMACOKINETICS, TISSUE DISTRIBUTION, AND IN-VIVO ANTITUMOR EFFECTS OF THE ANTIMELANOMA IMMUNOTOXIN ZME-GELONIN
Authors: MUJOO K CHEUNG L MURRAY JL ROSENBLUM MG
Citation: K. Mujoo et al., PHARMACOKINETICS, TISSUE DISTRIBUTION, AND IN-VIVO ANTITUMOR EFFECTS OF THE ANTIMELANOMA IMMUNOTOXIN ZME-GELONIN, Cancer immunology and immunotherapy, 40(5), 1995, pp. 339-345
ENHANCED TAG-72 EXPRESSION AND TURNER UPTAKE OF RADIOLABELED MONOCLONAL-ANTIBODY CC49 IN METASTATIC BREAST-CANCER PATIENTS FOLLOWING ALPHA-INTERFERON TREATMENT
Authors: MURRAY JL MACEY DJ GRANT EJ ROSENBLUM MG KASI LP ZHANG HZ GATZ RL RIEGER PT LEBHERZ D BHADKAMKAR V GREINER JW SCHLOM J PODOLOFF DA
Citation: Jl. Murray et al., ENHANCED TAG-72 EXPRESSION AND TURNER UPTAKE OF RADIOLABELED MONOCLONAL-ANTIBODY CC49 IN METASTATIC BREAST-CANCER PATIENTS FOLLOWING ALPHA-INTERFERON TREATMENT, Cancer research, 55(23), 1995, pp. 5925-5928
PHASE-I CLINICAL AND PHARMACOLOGICAL STUDY OF SUPPRESSION OF HUMAN ANTIMOUSE ANTIBODY-RESPONSE TO MONOCLONAL-ANTIBODY L6 BY DEOXYSPERGUALIN
Authors: DHINGRA K FRITSCHE H MURRAY JL LOBUGLIO AF KHAZAELI MB KELLEY S TEPPER MA GRASELA D BUZDAR A VALERO V BOOSER D WHEALIN H COLLINS TJ PURSLEY JM HORTOBAGYI G
Citation: K. Dhingra et al., PHASE-I CLINICAL AND PHARMACOLOGICAL STUDY OF SUPPRESSION OF HUMAN ANTIMOUSE ANTIBODY-RESPONSE TO MONOCLONAL-ANTIBODY L6 BY DEOXYSPERGUALIN, Cancer research, 55(14), 1995, pp. 3060-3067
WD(A) AND RB-A BLOOD-GROUP ANTIGENS ARE LOCATED IN THE THIRD ECTOPLASMIC LOOP OF THE ERYTHROID BAND-3 PROTEIN
Authors: JAROLIM P MURRAY JL RUBIN HL SMART E MOULDS JM
Citation: P. Jarolim et al., WD(A) AND RB-A BLOOD-GROUP ANTIGENS ARE LOCATED IN THE THIRD ECTOPLASMIC LOOP OF THE ERYTHROID BAND-3 PROTEIN, Blood, 86(10), 1995, pp. 1768-1768
OSTWALD RIPENING IN CONCENTRATED ALLOYS
Authors: CALDERON HA VOORHEES PW MURRAY JL KOSTORZ G
Citation: Ha. Calderon et al., OSTWALD RIPENING IN CONCENTRATED ALLOYS, Acta metallurgica et materialia, 42(3), 1994, pp. 991-1000
EFFECT OF TUMOR-NECROSIS-FACTOR-ALPHA ON BIODISTRIBUTION OF AN ANTIEPIDERMAL GROWTH-FACTOR RECEPTOR (EGFR) MONOCLONAL-ANTIBODY IN-VIVO
Authors: MURRAY JL WILMANNS C KILBOURN R MUJOO K KASI LP ZHANG HZ DONATO N ROSENBLUM MG
Citation: Jl. Murray et al., EFFECT OF TUMOR-NECROSIS-FACTOR-ALPHA ON BIODISTRIBUTION OF AN ANTIEPIDERMAL GROWTH-FACTOR RECEPTOR (EGFR) MONOCLONAL-ANTIBODY IN-VIVO, Antibody immunoconjugates, and radiopharmaceuticals, 7(4), 1994, pp. 261-275
TUMOR EPIDERMAL GROWTH-FACTOR RECEPTOR STUDIES IN PATIENTS WITH NON-SMALL-CELL LUNG-CANCER OR HEAD AND NECK-CANCER TREATED WITH MONOCLONAL-ANTIBODY RG-83852 (VOL 12, PG 730, 1994)
Authors: PEREZSOLER R DONATO NJ SHIN DM ROSENBLUM MG ZHANG HZ TORNOS C BRENER H CHAN JC LEE JS HONG WK MURRAY JL
Citation: R. Perezsoler et al., TUMOR EPIDERMAL GROWTH-FACTOR RECEPTOR STUDIES IN PATIENTS WITH NON-SMALL-CELL LUNG-CANCER OR HEAD AND NECK-CANCER TREATED WITH MONOCLONAL-ANTIBODY RG-83852 (VOL 12, PG 730, 1994), Journal of clinical oncology, 12(7), 1994, pp. 1526-1526
TUMOR EPIDERMAL GROWTH-FACTOR RECEPTOR STUDIES IN PATIENTS WITH NON-SMALL-CELL LUNG-CANCER OR HEAD AND NECK-CANCER TREATED WITH MONOCLONAL-ANTIBODY RG-83852
Authors: PEREZSOLER R DONATO NJ SHIN DM ROSENBLUM MG ZHANG HZ TORNOS C BREWER H CHAN JC LEE JS HONG WK MURRAY JL
Citation: R. Perezsoler et al., TUMOR EPIDERMAL GROWTH-FACTOR RECEPTOR STUDIES IN PATIENTS WITH NON-SMALL-CELL LUNG-CANCER OR HEAD AND NECK-CANCER TREATED WITH MONOCLONAL-ANTIBODY RG-83852, Journal of clinical oncology, 12(4), 1994, pp. 730-739
PHASE-I TRIAL OF MURINE MONOCLONAL-ANTIBODY 14G2 A ADMINISTERED BY PROLONGED INTRAVENOUS-INFUSION IN PATIENTS WITH NEUROECTODERMAL TUMORS
Authors: MURRAY JL CUNNINGHAM JE BREWER H MUJOO K ZUKIWSKI AA PODOLOFF DA KASI LP BHADKAMKAR V FRITSCHE HA BENJAMIN RS LEGHA SS ATER JL JAFFE N ITOH K ROSS MI BUCANA CD THOMPSON L CHEUNG L ROSENBLUM MG
Citation: Jl. Murray et al., PHASE-I TRIAL OF MURINE MONOCLONAL-ANTIBODY 14G2 A ADMINISTERED BY PROLONGED INTRAVENOUS-INFUSION IN PATIENTS WITH NEUROECTODERMAL TUMORS, Journal of clinical oncology, 12(1), 1994, pp. 184-193
CLINICAL-PHARMACOLOGY AND TISSUE DISPOSITION STUDIES OF I-131-LABELEDANTICOLORECTAL CARCINOMA HUMAN MONOCLONAL-ANTIBODY LICO-16.88
Authors: ROSENBLUM MG LEVIN B ROH M HOHN D MCCABE R THOMPSON L CHEUNG L MURRAY JL
Citation: Mg. Rosenblum et al., CLINICAL-PHARMACOLOGY AND TISSUE DISPOSITION STUDIES OF I-131-LABELEDANTICOLORECTAL CARCINOMA HUMAN MONOCLONAL-ANTIBODY LICO-16.88, Cancer immunology and immunotherapy, 39(6), 1994, pp. 397-400
PHASE-II TRIAL OF I-131 CC49 PLUS ALPHA-INTERFERON (RIFN] IN REFRACTORY METASTATIC BREAST-CANCER
Authors: PODOLOFF DA BHADKAMKAR VA KASI LP MACEY DJ ROSENBLUM MG GRANT EJ ZHANG HZ KATZ RL REIGER PT LEBHERZ D SOUTH MS DHINGRA K GREINER JW SCHLOM J MURRAY JL
Citation: Da. Podoloff et al., PHASE-II TRIAL OF I-131 CC49 PLUS ALPHA-INTERFERON (RIFN] IN REFRACTORY METASTATIC BREAST-CANCER, The Journal of nuclear medicine, 35(5), 1994, pp. 160000101-160000101
HOW WELL DOES THE DIAGNOSTIC STUDY PREDICT RED MARROW DOSE IN RADIOIMMUNOTHERAPY PATIENTS CHALLENGED WITH INTERFERON
Authors: MACEY DC MURRAY JL GRANT EJ PODOLOFF DA
Citation: Dc. Macey et al., HOW WELL DOES THE DIAGNOSTIC STUDY PREDICT RED MARROW DOSE IN RADIOIMMUNOTHERAPY PATIENTS CHALLENGED WITH INTERFERON, The Journal of nuclear medicine, 35(5), 1994, pp. 160000111-160000111
PREOPERATIVE STAGING OF PRIMARY BREAST-CANCER BY IMMUNOLYMPHOSCINTIGRAPHY (ILS)
Authors: PECKING AP BERTRAND FJ LOKIEC FM MURRAY JL SUBRAMANIAN R BOUDINET A FLOIRAS JL HANNA MG DEJAGER RL
Citation: Ap. Pecking et al., PREOPERATIVE STAGING OF PRIMARY BREAST-CANCER BY IMMUNOLYMPHOSCINTIGRAPHY (ILS), Lymphology, 27, 1994, pp. 245-248
COMPARATIVE TUMOR-LOCALIZATION OF WHOLE IMMUNOGLOBULIN-G ANTICARCINOEMBRYONIC ANTIGEN MONOCLONAL-ANTIBODIES IMMU-4 AND IMMU-4 F(AB')2 IN COLORECTAL-CANCER PATIENTS
Authors: MURRAY JL ROSENBLUM MG ZHANG HZ PODOLOFF DA KASI LP CURLEY SA CHAN JC ROH M HOHN DC BREWER H CUNNINGHAM JE THOMPSON LB BHADKAMKAR V PINSKY CM FOGLER WE
Citation: Jl. Murray et al., COMPARATIVE TUMOR-LOCALIZATION OF WHOLE IMMUNOGLOBULIN-G ANTICARCINOEMBRYONIC ANTIGEN MONOCLONAL-ANTIBODIES IMMU-4 AND IMMU-4 F(AB')2 IN COLORECTAL-CANCER PATIENTS, Cancer, 73(3), 1994, pp. 850-857
PHASE-II RADIOIMMUNOTHERAPY TRIAL WITH I-131 CC49 IN COLORECTAL-CANCER
Authors: MURRAY JL MACEY DJ KASI LP RIEGER P CUNNINGHAM J BHADKAMKAR V ZHANG HZ SCHLOM J ROSENBLUM MG PODOLOFF DA
Citation: Jl. Murray et al., PHASE-II RADIOIMMUNOTHERAPY TRIAL WITH I-131 CC49 IN COLORECTAL-CANCER, Cancer, 73(3), 1994, pp. 1057-1066
A PHASE-I PHARMACOKINETIC, TOXICITY AND DOSIMETRY STUDY OF I-131-LABELED IMMU-4 F(AB')2 IN PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA
Authors: ROSENBLUM MG MACEY D PODOLOFF D KASI L BAYOUTH J CUNNINGHAM J BHADKAMKAR V RIEGER P THOMPSON LB CHEUNG L PINSKY C SHARKEY R MURRAY JL
Citation: Mg. Rosenblum et al., A PHASE-I PHARMACOKINETIC, TOXICITY AND DOSIMETRY STUDY OF I-131-LABELED IMMU-4 F(AB')2 IN PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA, Antibody immunoconjugates, and radiopharmaceuticals, 6(4), 1993, pp. 239-255
PHASE-II TRIAL OF CC-49 IN REFRACTORY COLON CANCER
Authors: PODOLOFF DA KASI LP MACEY DM BHADKAMKAR VA RIEGER P CUNNINGHAM J SOUTH M ZHANG HZ ROSENBLUM MG SCHLOM J MURRAY JL
Citation: Da. Podoloff et al., PHASE-II TRIAL OF CC-49 IN REFRACTORY COLON CANCER, The Journal of nuclear medicine, 34(5), 1993, pp. 53-53
USE OF ANTI-B4-BLOCKED RICIN AS AN IMMUNOSUPPRESSANT
Authors: ESSELTINE DL BRAMAN GM PARK Y LEVINE AM MCLAUGHLIN P MURRAY JL GROSSBARD M LYNCH T RITZ J NADLER L EPSTEIN CL
Citation: Dl. Esseltine et al., USE OF ANTI-B4-BLOCKED RICIN AS AN IMMUNOSUPPRESSANT, Blood, 82(10), 1993, pp. 10000240-10000240
Risultati: 1-25 | 26-50 |